Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies
Mika L. Persson, Alicia M. Douglas, Frank Alvaro, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 9, pp. 1408-1422
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Evangeline R. Jackson, Ryan J. Duchatel, Dilana E. Staudt, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2421-2437
Open Access | Times Cited: 54
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
Iker Ausejo‐Mauleon, Sara Labiano, Daniel de la Nava, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1911-1926.e8
Open Access | Times Cited: 48
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors
Frank Y. Lin, Austin J. Stuckert, Candise Tat, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 23, pp. 2769-2779
Open Access | Times Cited: 22
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma
Ryan J. Duchatel, Evangeline R. Jackson, Sarah Parackal, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 13
B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers
Tabitha McLachlan, William C. Matthews, Evangeline R. Jackson, et al.
Molecular Cancer Research (2022) Vol. 20, Iss. 12, pp. 1711-1723
Open Access | Times Cited: 30
CAR T cell therapies for diffuse midline glioma
Bryce C. Thomas, Dilana E. Staudt, Alicia M. Douglas, et al.
Trends in cancer (2023) Vol. 9, Iss. 10, pp. 791-804
Open Access | Times Cited: 20
Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironment
Adrian Levine, Liana Nobre, Anirban Das, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
Lauren Arms, Ryan J. Duchatel, Evangeline R. Jackson, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 835-865
Open Access | Times Cited: 6
Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma
Yujia Chen, Chao Zhao, Shenglun Li, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 602-602
Open Access | Times Cited: 16
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma
Stacie Shiqi Wang, Alexander J. Davenport, Melinda Iliopoulos, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 16
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas
Aleeha Noon, Stefanie Galbán
Neoplasia (2023) Vol. 40, pp. 100899-100899
Open Access | Times Cited: 15
A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered
Evangeline R. Jackson, Mika L. Persson, Cameron J Fish, et al.
Neuro-Oncology (2023) Vol. 26, Iss. Supplement_2, pp. S136-S154
Open Access | Times Cited: 14
New progress in the treatment of diffuse midline glioma with H3K27M alteration
Zhi Yang, Liang Sun, Hai‐Bin Chen, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24877-e24877
Open Access | Times Cited: 5
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions
Martin J. van den Bent, Amanda Saratsis, Marjolein Geurts, et al.
Neuro-Oncology (2023) Vol. 26, Iss. Supplement_2, pp. S110-S124
Open Access | Times Cited: 11
The rise of TIM‐3: A promising immune target in diffuse midline gliomas
Iker Ausejo‐Mauleon, Sara Nuin, Marta M. Alonso
Clinical and Translational Medicine (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Targeted treatment of solid tumors in pediatric precision oncology
Ilaria Bertacca, Francesco Pegoraro, Annalisa Tondo, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Transforming Growth Factor Beta 2 (TGFB2) and Interferon Gamma Receptor 2 (IFNGR2) mRNA Levels in the Brainstem Tumor Microenvironment (TME) Significantly Impact Overall Survival in Pediatric DMG Patients
Sanjive Qazi, Zahra Talebi, Vuong Trieu
Biomedicines (2024) Vol. 12, Iss. 1, pp. 191-191
Open Access | Times Cited: 3
Gross tumor volume increase and need for adaptive radiotherapy in pediatric-type diffuse high-grade glioma of the midline structures
Fasco van Ommen, Toon Van Genechten, Mirjam Willemsen-Bosman, et al.
Radiotherapy and Oncology (2025), pp. 110873-110873
Open Access
Beyond Base Camp: Promise and Pitfalls of PI3K/mTOR Inhibition in Pediatric High- Grade Gliomas
Ryan J. Duchatel, Clara Savary, Zacary P. Germon, et al.
(2025)
Closed Access
Radiotherapy and radio‐sensitization in H3K27M‐mutated diffuse midline gliomas
Chao Liu, Shuwen Kuang, Lei Wu, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 7, pp. 1721-1737
Open Access | Times Cited: 7
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology
Jessica Foster, Marta M. Alonso, Elias Sayour, et al.
Neoplasia (2023) Vol. 42, pp. 100909-100909
Open Access | Times Cited: 7
Comprehensive Analysis Identified Glycosyltransferase Signature to Predict Glioma Prognosis and TAM Phenotype
Yiwei Qi, Wenchang Lv, Xiaojin Liu, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 6
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma
Alyssa Noll, Carrie Myers, Matthew C. Biery, et al.
Neoplasia (2023) Vol. 43, pp. 100921-100921
Open Access | Times Cited: 5
The Clinical and Molecular Landscape of Rosette-Forming Glioneuronal Tumors
Zijiang Yang, Xiaobiao Zhang
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2325-2325
Open Access | Times Cited: 1
Chimeric antigen receptor T-cell therapy in patients with malignant glioma—From neuroimmunology to clinical trial design considerations
Marco Gallus, Jacob S. Young, Sarah Cook Quackenbush, et al.
Neuro-Oncology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top